Risperidone Treatment in Dually-Diagnosed Individuals - 2
Phase 2
Completed
- Conditions
- Cocaine-Related Disorders
- Registration Number
- NCT00000267
- Lead Sponsor
- National Institute on Drug Abuse (NIDA)
- Brief Summary
The purpose of this study is to evaluate the safety and efficacy of risperidone for cocaine dependence in individuals with schizophrenia/schizoaffective illness.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
Not provided
Exclusion Criteria
Not provided
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Craving Side effects Drug use Psychiatric symptoms
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
New York State Psychiatric Institute
🇺🇸New York, New York, United States